￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Rubitidine is a second-line treatment drug for small cell lung cancer_ Kanghule

2025-10-19 11:44:20

Check Details
Ramucirumab can significantly prolong the survival of patients with non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Efficacy of rubitidine in the treatment of small cell lung cancer that progresses after platinum-based chemotherapy

2025-10-19 11:44:20

Check Details
Where to buy ramucirumab? How much does it cost?

2025-10-19 11:44:20

Check Details
Small cell lung cancer welcomes new second-line treatment drug - rupitidine

2025-10-19 11:44:20

Check Details
The cost of ramucirumab treatment for patients with lung cancer_Canghule

2025-10-19 11:44:20

Check Details
Ramucirumab effectively improves the survival of metastatic NSCL patients carrying EGFR gene mutations

2025-10-19 11:44:20

Check Details
What are the FDA-approved indications for ramucirumab?

2025-10-19 11:44:20

Check Details
How much does a box of rupees cost? Where can I buy it?

2025-10-19 11:44:20

Check Details
Effects and adverse reactions of ramucirumab in the treatment of non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Ramucirumab combined with docetaxel for metastatic non-small cell lung cancer_Canghule

2025-10-19 11:44:20

Check Details
Safety and effectiveness of rubitidine in the treatment of small cell lung cancer

2025-10-19 11:44:20

Check Details
Category
相关知识